The Food and Drug Administration is allowing the marketing of two new tobacco products under regulations that allow tobacco companies to market products if they can prove they are similar enough to ones already on the market.
States that want to reduce rates of adult smoking may consider implementing stringent tobacco restrictions on teens, suggested a new study released by researchers at Washington University School of Medicine in St. Louis on Thursday.
Researchers from the Perelman School of Medicine at the University of Pennsylvania last week reported that an area of the brain that initiates behavioral changes had greater activation in smokers who watched anti-smoking ads with strong arguments versus those with weaker ones, and irrespective of such flashy elements as bright and rapidly changing scenes, loud sounds and unexpected scenario twists.
A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.
GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.
In spite of a court ruling striking down a ban on large-sized sugary drinks, New York mayor Michael Bloomberg has another health initiative in the works: a requirement that retailers hide tobacco products.
New results from a national online public opinion poll of Americans 18 and older show that 34% of smokers plan to quit smoking as a New Year’s resolution in 2013, as compared to only 18% who reported that quitting smoking was a New Year’s resolution in 2012.